|
US6352694B1
(en)
|
1994-06-03 |
2002-03-05 |
Genetics Institute, Inc. |
Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
|
|
US6905680B2
(en)
|
1988-11-23 |
2005-06-14 |
Genetics Institute, Inc. |
Methods of treating HIV infected subjects
|
|
US5858358A
(en)
|
1992-04-07 |
1999-01-12 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for selectively stimulating proliferation of T cells
|
|
US6534055B1
(en)
|
1988-11-23 |
2003-03-18 |
Genetics Institute, Inc. |
Methods for selectively stimulating proliferation of T cells
|
|
US7175843B2
(en)
|
1994-06-03 |
2007-02-13 |
Genetics Institute, Llc |
Methods for selectively stimulating proliferation of T cells
|
|
US7067318B2
(en)
|
1995-06-07 |
2006-06-27 |
The Regents Of The University Of Michigan |
Methods for transfecting T cells
|
|
US6692964B1
(en)
|
1995-05-04 |
2004-02-17 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for transfecting T cells
|
|
US6489458B2
(en)
|
1997-03-11 |
2002-12-03 |
Regents Of The University Of Minnesota |
DNA-based transposon system for the introduction of nucleic acid into DNA of a cell
|
|
EP1146898A1
(en)
*
|
1999-01-22 |
2001-10-24 |
Matthew John During |
Vaccine-mediated treatment of neurological disorders
|
|
US6867041B2
(en)
|
2000-02-24 |
2005-03-15 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
CA2406864A1
(en)
|
2000-02-24 |
2001-08-30 |
Life Technologies Corporation |
Simultaneous stimulation and concentration of cells
|
|
US6797514B2
(en)
|
2000-02-24 |
2004-09-28 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
US7634360B2
(en)
*
|
2003-09-23 |
2009-12-15 |
Prediction Sciences, LL |
Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
|
|
WO2008021408A2
(en)
*
|
2006-08-15 |
2008-02-21 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for treatment and diagnosis of autoimmune encephalitis or epilepsy
|
|
EP2160461B1
(en)
|
2007-07-04 |
2012-08-08 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Hyperactive variants of the transposase protein of the transposon system sleeping beauty
|
|
CN101874895B
(zh)
*
|
2009-02-17 |
2013-01-02 |
南京大学医学院附属鼓楼医院 |
Cart作为制备治疗阿尔茨海默病药物的应用
|
|
US20120142543A1
(en)
*
|
2010-11-29 |
2012-06-07 |
Kenneth Blum |
Methods to assess treatment outcomes in Reward Deficiency Syndrome (RDS)
behaviors utilizing expression profiling
|
|
US8648198B2
(en)
*
|
2011-01-19 |
2014-02-11 |
Cold Spring Harbor Laboratory |
Phenylethanolamine-based NMDA receptor antagonists
|
|
DK3166968T3
(da)
|
2014-05-02 |
2021-12-06 |
Univ Pennsylvania |
Sammensætninger og fremgangsmåder til kimæriske autoantistofreceptor-T-celler
|
|
GB201409234D0
(en)
|
2014-05-23 |
2014-07-09 |
Isis Innovation |
Method
|
|
US20180244802A1
(en)
*
|
2015-08-17 |
2018-08-30 |
Deutsches Zentrum Fur Neurodegenerative Erkrankungen E.V. (Dzne) |
Antibody or antibody fragment of non-ig scaffold binding to a binding region of an anti-n-methyl-d-aspartate (nmda) receptor antibody
|
|
SG10202012157QA
(en)
*
|
2016-06-07 |
2021-01-28 |
Max Delbrueck Centrum Fuer Molekulare Medizin Helmholtz Gemeinschaft |
Chimeric antigen receptor and car-t cells that bind bcma
|
|
CN107857712B
(zh)
*
|
2016-09-22 |
2022-09-09 |
烟台益诺依生物医药科技有限公司 |
(r)-3-甲基-2-(3-氧代酰胺基)正丁酸酯
|
|
WO2018127585A1
(en)
|
2017-01-06 |
2018-07-12 |
Txcell |
Monospecific regulatory t cell population with cytotoxicity for b cells
|
|
EP3346001A1
(en)
*
|
2017-01-06 |
2018-07-11 |
TXCell |
Monospecific regulatory t cell population with cytotoxicity for b cells
|
|
CN112423793A
(zh)
*
|
2018-06-05 |
2021-02-26 |
宾夕法尼亚大学董事会 |
肌肉特异性激酶嵌合自身抗体受体细胞的组合物和方法
|